MTUM: $20B Momentum ETF Not The Best Choice In Its Category

MTUM (iShares MSCI USA Momentum Factor ETF) is a $19.6B large‑cap momentum ETF (0.15% expense) that tracks the MSCI USA Momentum SR Variant Index—selecting 125 names by risk‑adjusted 6‑ and 12‑month momentum, with index rules that cap single‑stock weights and quarterly turnover at 30% (the fund’s reported portfolio turnover has been ~116%). While MTUM has strong long‑run returns (10‑year total return ~291.7%) and concentrated exposure to tech (32.8%) with top 10 positions at ~42%, its six‑month momentum is relatively weak (+16.1%), its holdings show high leverage versus peers, and newer ETFs (FDMO, SEIM) and rival SPMO have outperformed on recent horizons or offer better short‑term momentum and margin/quality metrics. Conclusion: MTUM remains a viable, low‑cost core momentum vehicle but is rated a hold as it may cede market share to SPMO and newer entrants that currently deliver stronger short‑term momentum and slightly better fundamental profiles.

Analysis

MTUM is a $19.6 billion large-cap momentum ETF with a 0.15% expense ratio that tracks the MSCI USA Momentum SR Variant Index; its portfolio is concentrated in Technology (32.83%) with top 10 holdings representing ~42% of assets and notable exceedances of the 5% cap for Broadcom and JPMorgan due to post-rebalance outperformance. The fund’s reported portfolio turnover (~116%) contrasts with the Index’s 30% quarterly turnover cap, suggesting either intra-period trading or reporting differences and raising the risk that MTUM may be slow to excise deteriorating momentum names after rebalances. MTUM’s constituents delivered only 16.05% six‑month price gains versus a 40.83% one‑year gain, and its relative rank has slipped (three‑year 78.41% rank #8/19; five‑year 90.31% rank #12/17) despite a ten‑year total return of 291.74% (rank #2/5). Competing ETFs present tradeoffs: SPMO shows stronger margin and ROTC metrics (SPMO ROTC 17.68%) and better recent historical returns, while newcomers FDMO and SEIM offer superior short‑term momentum and more attractive PEG-adjusted valuations, supporting the author’s hold rating and the view that MTUM may cede market share.

Key Decisions for Investors

• Maintain a neutral/hold stance on MTUM rather than adding new exposure given weaker recent six‑month momentum and rising competition from SPMO and newer ETFs
• Consider reallocating incremental core momentum exposure toward SPMO if the priority is historical outperformance and stronger margin/quality metrics, as noted by the ROTC and profitability comparisons
• Allocate small tactical positions to FDMO or SEIM to capture stronger short‑term momentum and more attractive PEG-adjusted profiles, sizing these as experiments rather than core replacements
• Monitor the next quarterly rebalance and fund filings for continued weight breaches (>5%), changes in six‑month momentum, and realization of the stated 30% turnover cap; trim or hedge MTUM exposure if concentration or leverage (1.26x D/E) materially increases portfolio risk